| dc.contributor.author | Pavord, Sue et al. | |
| dc.date.accessioned | 2020-05-12T18:14:04Z | |
| dc.date.available | 2020-05-12T18:14:04Z | |
| dc.date.issued | 2020-05-06 | |
| dc.identifier.uri | https://doi.org/10.1111/bjh.16775 | en_US |
| dc.identifier.uri | https://hdl.handle.net/20.500.12663/1442 | |
| dc.description.abstract | This document aims to provide practical guidance for the assessment and management of patients with thrombocytopenia, with a particular focus on Immune Thrombocytopenia (ITP) during the COVID‐19 pandemic. The intention is to support clinicians and, although recommendations have been provided, it is not a formal guideline. Nor is there sufficient evidence base to conclude that alternative approaches to treatment are incorrect. Instead, it is a consensus written by clinicians with an interest in ITP or coagulation disorders and reviewed by members of the UK ITP forum. | en_US |
| dc.language | English | en_US |
| dc.subject | COVID-19 | en_US |
| dc.subject | Coronavirus | en_US |
| dc.subject | Infectious Diseases | en_US |
| dc.subject | Thrombocytopenia | en_US |
| dc.title | Practical guidance for the management of adults with Immune Thrombocytopenia during the COVID‐19 pandemic | en_US |
| eihealth.country | Others | en_US |
| eihealth.category | Clinical characterization and management | en_US |
| eihealth.type | Other publications | en_US |
| eihealth.maincategory | Save Lives / Salvar Vidas | en_US |
| dc.relation.ispartofjournal | British Journal of Haematology | en_US |
